In rNK cells from NASH, we found GZMK and the inhibitory receptor CD96 were upregulated, while cNK cells overexpressed the chemokines CCL3 and CCL4, the activation marker CD69, and the chemokine receptor CXCR4. This evidence concerns the gene CD96 and metabolic dysfunction-associated steatohepatitis.